Survey: U.S. neurologists would prescribe Leqembi if fully approved
By
Alicia Lasek
Apr 12, 2023
A “healthy proportion” of surveyed neurologists have already begun prescribing the treatment, and nearly all said they planned to do so if traditional FDA approval is granted.
Do you want to know that you’ll develop Alzheimer’s? For many, the answer is yes
By
Alicia Lasek
Jan 02, 2020
Most adults want to know that they have Alzheimer’s disease before symptoms appear, finds a UK survey. And 75% are willing to be tested.
Two-thirds of neurologists expect to start some patients on Aduhelm next year: survey
By
Alicia Lasek
Sep 17, 2021
The outlook for the Alzheimer’s drug aducanumab (Aduhelm) is looking up, investigators say. There are small increases in the number of Aduhelm prescribers, and an uptick in patients for whom the...
Clinical Briefs for Monday, April 13
By
Alicia Lasek
Apr 12, 2020
More than 2,200 COVID-19 deaths in nursing homes … Lack of data, testing puts residents at risk of coronavirus: provider survey … More evidence found that ultrasound can aid in delivering future Alzheimer’s...
PPIs do not raise dementia risk, review finds
By
Alicia Lasek
Jan 06, 2020
There is no link between a common class of acid reflux medications and increased dementia risk, according to a new analysis.
Clinical Briefs for Friday, May 22
By
Alicia Lasek
May 21, 2020
Infection control problems ‘persisted’ at nursing homes prior to pandemic: GAO … New AARP report spotlights Alzheimer’s toll on women … Emerging medical countermeasures to COVID-19 may be best...
Vascular risk factors raise odds of Alzheimer’s disease in Blacks, Hispanics: study
By
Alicia Lasek
Jan 05, 2023
Vascular risk helps to explain the outsized odds of Alzheimer’s faced by African Americans and Hispanics in the United States, a new study has found.
Medicare costs could rise by $5B annually with expanded Alzheimer’s drug coverage: study
By
Alicia Lasek
May 12, 2023
Medicare costs could rise by $2 to $5 billion a year if CMS expands its coverage for newly approved Alzheimer’s disease drug Leqembi (lecanemab), investigators say.
Hurricanes hastened the deaths of adults with dementia, study finds
By
Alicia Lasek
Mar 08, 2023
People with Alzheimer’s and related dementias (ADRD) had higher mortality rates in U.S. counties that had recently experienced a hurricane disaster, investigators report.
Vitamin D may protect against Alzheimer’s, new report asserts
By
Alicia Lasek
Mar 06, 2023
Exposure to vitamin D supplements is linked to longer dementia-free survival and a lower rate of dementia when compared to no exposure, a new study has found.